Physician profile
Ashley E Waldrop
NPI 1487088811
$174.18
in general payments reported to CMS, 2019-2025
7 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.03 · 2024: $48.32 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152 · Education: $22.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.18 |
| Education | $22.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $39.10 | 2025 | Tavneos |
| Akebia Therapeutics INC | $27.98 | 2024 | Vafseo, Auryxia |
| Vifor Pharma, INC. | $27.90 | 2025 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $22.23 | 2025 | |
| Travere Therapeutics, INC. | $22.00 | 2024-2025 | Filspari |
| Invivyd INC | $18.94 | 2025 | Pemgarda |
| Merck Sharp & Dohme LLC | $16.03 | 2023 | Prevymis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.